Dr Anil Kumar Singhi

Dr. Anil Kumar Singhi, a Gold Medalist in MD (Paediatrics), has earned prestigious fellowships including FNB, FRCPCH, and FACC, making him one of the leading experts in Paediatric Cardiology. He has successfully performed numerous transcatheter interventions, enabling heart defect closures without the need for surgery. His advanced skills in transthoracic, transesophageal, and fetal echocardiography allow for early and accurate diagnosis of congenital heart diseases. Alongside his clinical practice, Dr. Singhi is deeply committed to education and research, consistently contributing to the advancement of innovative paediatric and structural cardiology treatments.

Educational Qualifications:

• MBBS
• MD (Paediatrics) – Gold Medal
• FNB (Paediatric Cardiology)
• FRCPCH, FACC

Professional Experience:

• 18+ years in Paediatrics; 12+ years focused on Paediatric Cardiology
• Senior Consultant, Paediatric Cardiology – Manipal Hospitals, E.M. Bypass, Kolkata
• Extensive experience in complex transcatheter structural heart interventions

Professional Memberships:

• Life Member – Indian Academy of Pediatrics (IAP)
• Life Member – National Neonatology Forum (NNF)
• Life Member – Indian Medical Association (IMA)
• Life Member – Pediatric Cardiac Society of India (PCSI)
• Life Member – Cardiology Society of India (CSI)

Certifications:

• Gold Medal – MD (Paediatrics)
• Advanced fellowships/board credentials: FNB (Paediatric Cardiology), FRCPCH, FACC

Awards and Achievements:

• Young Investigator Award (PCSI, Kochi, 2008) – work on ASD & pulmonary hypertension
• Best Case/Presentation awards (e.g., EZECHO 2016, Kolkata)
• Merit & Gold Medal recognitions in Paediatrics; PG entrance top rank (NRSMC)

Publications:

• Multiple peer-reviewed works in Annals of Pediatric Cardiology, J Cardiovasc Imaging, Cureus, Progress in Pediatric Cardiology, Indian J Pediatr, etc.
• Topics include congenital & structural heart disease interventions, ASD/VSD device closure, complications & strategies in valvotomy, post-COVID inflammatory states, Fontan/hemodynamic innovations, and pulmonary hypertension